In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...
Specialists call for early screening for better prevention and early treatment By Kumudini Hettiarachchi The largest solid ...
A newly developed MRI-based scoring system may help identify patients at higher risk of early recurrence after surgical removal of small hepatocellular carcinoma (HCC). The findings, published in ...
Psychologically, it's really hard knowing that we aren’t doing anything to stop the cancer growing.
Immunic (NASDAQ:IMUX) executives outlined their multiple sclerosis (MS) development strategy and commercial thinking for vidofludimus calcium during a session at the Leerink Partners Global Healthcare ...
Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...
Liver ultrasound is a safe, non-invasive imaging test that helps doctors check liver structure, fat levels, and tissue ...
The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Martin Gleave discussing how to optimize tissue biopsy ...
Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...
Opinion
The Oldham Times on MSNOpinion
‘If this were affecting men, how long would they put up with it?'
An Oldham who has endometriosis said she has felt 'ignored' and 'dismissed' about her 'horrific' pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results